Found 5 matching trials
OCR002-SP103 - Oral Immediate Release Study
PHASE1This is an open-label Phase 1, 2-part, crossover study in approximately 33 ...
Location
Southern California Research Center
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
PHASE2The main objective is to evaluate the effectiveness of the experimental dru...
Location
Hospital Vall Hebron
Emergency Use of OCR-002 in Acute Liver Failure (ALF)
N/AThis study provides emergency use of the unapproved study medication in ALF...
Status
No Longer Available
Location
University of Arkansas
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
PHASE2This Phase 2a clinical study is designed to provide data on OCR-002 in pati...
Location
University of California, San Francisco
Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
PHASE2The purpose of this study is to determine whether ornithine phenylacetate c...
Location
Multiple Locations